| Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468) |
|---|
| 04/18/2007 | EP1425276B1 Heterocyclic carboxamides and their use as fungicides |
| 04/17/2007 | US7205305 Inhibitors of p38 |
| 04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
| 04/17/2007 | CA2299300C Arylpyridazinones as prostaglandin endoperoxide h synthase bisoynthesis inhibitors |
| 04/12/2007 | WO2007039463A1 Nnrt inhibitors |
| 04/12/2007 | US20070082910 Specific nad(p)h oxidase inhibitor |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | CA2623728A1 Nnrt inhibitors |
| 04/11/2007 | EP1351938B1 Phenyl derivatives |
| 04/11/2007 | CN1946699A Pyridazinone ureas as antagonists of alpha4 integrins |
| 04/10/2007 | USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease |
| 04/10/2007 | CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists |
| 04/05/2007 | WO2006086447A3 Pyridazine derivatives and their use as therapeutic agents |
| 04/05/2007 | US20070078128 5-[6-Chloro-2-fluoro-3-((R)-5-methyl-6-oxo-1,4,5,6-tetrahydro-[1,2,4]triazin-3-ylmethyl)-phenoxy]-isophthalonitrile; contacting a phenylacetic acid compound with an amino acid ester in presence of a coupling reagent to produce an intermediate, then with Lawesson's reagent, finally with hydrazine; AIDS |
| 04/05/2007 | CA2620878A1 Theramutein modulators |
| 04/04/2007 | CN1942449A Process for preparing pyridazinone compounds |
| 04/04/2007 | CN1939896A Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 03/28/2007 | EP1767529A1 Pyridazine compound and use thereof |
| 03/28/2007 | EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 03/28/2007 | CN1938283A Pyridazinones as antagonists of alpha4 integrins |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | US7196085 Phthalazinone derivatives |
| 03/27/2007 | US7196084 Cdc25 phosphatase inhibitors |
| 03/22/2007 | WO2007031791A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/22/2007 | WO2006060122A3 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066822 Ionic liquids |
| 03/22/2007 | US20070066619 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 03/22/2007 | CA2621364A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1763303A1 Substituted pyridazine carboxamides and derivatives thereof |
| 03/21/2007 | EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases |
| 03/21/2007 | CN1934092A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 03/21/2007 | CN1933839A Compounds and methods of use |
| 03/21/2007 | CN1305852C Diaryl ethers as opioid receptor antagonist |
| 03/20/2007 | US7192968 Ethylenediamine derivatives |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192953 Antibacterial agents |
| 03/15/2007 | WO2006060127A3 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| 03/15/2007 | US20070060748 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | CA2621406A1 Pparactive compounds |
| 03/14/2007 | EP1562936B1 Therapeutic piperazine compounds |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1304379C Water-soluble phenylpyridazine compounds and compositions containing the same |
| 03/13/2007 | US7189718 viricides; polymerase inhibitor; therapy for genetic engineered viruses |
| 03/08/2007 | WO2007027733A2 Reverse link soft handoff in a wireless multiple-access communication system |
| 03/08/2007 | WO2007027599A1 9-aminocarbonylsubstituted derivatives of glycylcyclines |
| 03/08/2007 | WO2007026771A1 Injection for intravenous drip |
| 03/08/2007 | WO2007026624A1 Method for producing 2,3-dihydropyridazine compound |
| 03/08/2007 | WO2007026623A1 Process for producing 3-amino-6-chloropyridazine |
| 03/08/2007 | CA2620600A1 9-aminocarbonylsubstituted derivatives of glycylcyclines |
| 03/07/2007 | EP1758869A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 03/07/2007 | CN1926097A Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 03/07/2007 | CN1923832A Novel pyridazinone compound, preparation method and application thereof |
| 03/06/2007 | US7186834 Substituted iminoazines |
| 03/06/2007 | US7186742 Benzamide inhibitors of the P2X7 receptor |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/01/2007 | WO2007022845A1 Novel materials for organic electroluminescent devices |
| 03/01/2007 | WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis |
| 03/01/2007 | US20070049595 Autoimmune disease; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents; osteoporosis |
| 02/28/2007 | EP1757600A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 02/28/2007 | EP1757592A1 Novel 3-phenyltetrahydrocinnolin-5-ol derivative and medicinal use thereof |
| 02/28/2007 | EP1756044A1 Therapeutic compounds |
| 02/28/2007 | EP1626962B1 Benzamide inhibitors of the p2x7 receptor |
| 02/28/2007 | CN1302116C Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative |
| 02/22/2007 | WO2007021858A2 Methods of making radiolabeled tracers and precursors thereof |
| 02/22/2007 | WO2006127379A3 Par2-modulating compounds and their use |
| 02/22/2007 | CA2618988A1 Methods of making radiolabeled tracers and precursors thereof |
| 02/21/2007 | EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 02/21/2007 | EP1753713A2 Synthesis of tetracyclines and analogues thereof |
| 02/21/2007 | EP1753429A1 Modulators of muscarinic receptors |
| 02/21/2007 | CN1918165A Azabicyclic heterocycles as cannabinoid receptor modulators |
| 02/21/2007 | CN1918164A Azabicyclic heterocycles as cannabinoid receptor modulators |
| 02/21/2007 | CN1918133A Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 02/15/2007 | US20070037813 Serine Protease Inhibitors |
| 02/15/2007 | US20070036716 Methods of making radiolabeled tracers and precursors thereof |
| 02/14/2007 | EP1751115A1 Theramutein modulators |
| 02/14/2007 | EP1751113A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176204 Substituted carboxylic acid derivatives |
| 02/13/2007 | CA2122236C Quinolines and their analogs |
| 02/13/2007 | CA2112420C N-arylhydrazine derivatives as insecticidal and acaricidal agents |
| 02/08/2007 | WO2007014607A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
| 02/08/2007 | US20070032496 Compounds for the Treatment of Neurodegeneration and Stroke |
| 02/08/2007 | CA2616682A1 Squaric acid derivatives as protein kinase inhibitors |
| 02/06/2007 | US7173025 Compounds for use as anticoagulants for treatment of arteries in brains and factor x inhibitors |
| 02/01/2007 | WO2007014226A2 Compounds for the treatment of neurodegeneration and stroke |
| 02/01/2007 | WO2006132811A3 Ampa receptor potentiators |
| 01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 01/31/2007 | CN1905882A Vascular intimal hyperplasia inhibitor |
| 01/31/2007 | CN1905873A Bicyclic inhibitors of MEK and methods of use thereof |
| 01/30/2007 | US7169325 liquid crystalline compound capable of exhibiting a biaxial liquid crystal phase |
| 01/25/2007 | WO2007009913A1 Pyridazinone derivatives as thyroid hormone receptor agonists |
| 01/25/2007 | US20070021427 Novel tricyclic derivatives and their use |